• J. Cardiothorac. Vasc. Anesth. · Jul 2022

    Six-Month Quality of Life in COVID-19 Intensive Care Unit Survivors.

    • Valery Likhvantsev, Giovanni Landoni, Sergey Perekhodov, Nikolay Chaus, Kristina Kadantseva, Lyubov Ermokhina, Anastasia Baeva, Mikhail Yadgarov, Levan Berikashvili, Artem Kuzovlev, and Andrey Grechko.
    • V. A. Negovsky Research Institute of General Reanimatology, Moscow, Russia; First Moscow State Medical University (Sechenov University), Moscow, Russia.
    • J. Cardiothorac. Vasc. Anesth. 2022 Jul 1; 36 (7): 194919551949-1955.

    ObjectivesBecause there is increasing evidence of serious deterioration in long-term quality of life (QoL) in coronavirus 2019 (COVID-19) intensive care unit (ICU) survivors, the authors identified predictors of poor quality of life in these patients.DesignProspective cohort study.SettingResearch hospital repurposed into a COVID-19 center.ParticipantsConsecutive patients admitted in COVID-19 ICUs between March and June 2020.InterventionsAn SF-36 questionnaire, which included physical and mental items, was used six months after patient's discharge.Measurements And Main ResultsA total of 403 patients were managed in the ICU, with a hospital mortality of 181 of 403 (44.9%), and 16 (4.0%) patients died within six months. Among the 125 questionnaire responders, only 32.0% and 52% had a normal quality of life in terms of the physical and mental component of health. Multivariate analysis identified low-molecular-weight heparin treatment in the ICU as the only modifiable factor associated with an increase in physical component of QoL odds ratio (OR) 3.341 (95% confidence interval 1.298-8.599), p = 0.012, and age ≥52 years OR 0.223 and female sex OR 0.321 were significantly associated with a decrease in the physical component. Medical history of cerebrovascular insufficiency was significantly associated with a decrease in mental component of QoL OR 0.125, and the only factor associated with an increase in the mental health component was body mass index ≥27.6 kg/m2 OR 7.466.ConclusionsIn COVID-19 ICU survivors the authors identified treatment with low- molecular-weight heparin as a predictor of improved physical component of QoL at 6 months.Copyright © 2021 Elsevier Inc. All rights reserved.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.